These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Radioimmunoscintigraphy with 99mTc-225.28S-F(ab')2 in cutaneous and ocular melanomas: cases of particular clinical interest. Salzillo F; Mele M; Lombardo T; Delle Noci N; Minervini C; D'Addabbo A J Nucl Biol Med (1991); 1993 Dec; 37(4):191-7. PubMed ID: 8172959 [TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy with anti-225.28S for ocular melanoma--a comparison with histology and immunohistochemistry. Bräutigam P; Loeffler KU; Krause T; Högerle S; Simon J; Moser E Nuklearmedizin; 1997 Mar; 36(2):42-6. PubMed ID: 9090646 [TBL] [Abstract][Full Text] [Related]
4. Radioimmunoscintigraphy in patients with ocular melanoma. Sergieva SB; Virtcheva-Genkova A Clin Nucl Med; 1997 Jan; 22(1):25-9. PubMed ID: 8993869 [TBL] [Abstract][Full Text] [Related]
5. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Siccardi AG; Buraggi GL; Callegaro L; Mariani G; Natali PG; Abbati A; Bestagno M; Caputo V; Mansi L; Masi R Cancer Res; 1986 Sep; 46(9):4817-22. PubMed ID: 3731128 [TBL] [Abstract][Full Text] [Related]
6. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments. Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860 [TBL] [Abstract][Full Text] [Related]
7. Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments. Bomanji J; Hungerford JL; Granowska M; Britton KE Br J Ophthalmol; 1987 Sep; 71(9):651-8. PubMed ID: 2822079 [TBL] [Abstract][Full Text] [Related]
8. [Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma]. Rentsch M; Cerny T; Richner J; Brunner KW; Rösler H; Nachbur B Helv Chir Acta; 1989 Jun; 56(1-2):11-3. PubMed ID: 2777587 [TBL] [Abstract][Full Text] [Related]
9. [Radioimmunoscintigraphy with a 99mTc-labeled F(ab')2 fragment of a monoclonal antibody (HMW-MAA 225.28S) in 71 patients with malignant melanoma]. Rentsch M; Cerny T; Geiger L; Gerber H; Brunner KW; Rösler H; Nachbur B Schweiz Med Wochenschr; 1989 Oct; 119(40):1382-5. PubMed ID: 2552577 [TBL] [Abstract][Full Text] [Related]
10. Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma. Magnani P; Paganelli G; Modorati G; Zito F; Songini C; Sudati F; Koch P; Maecke HR; Brancato R; Siccardi AG; Fazio F J Nucl Med; 1996 Jun; 37(6):967-71. PubMed ID: 8683323 [TBL] [Abstract][Full Text] [Related]
11. Scintigraphic visualization of ocular melanoma with Tc-99m glutathione. Tutuş A; Erkiliç K; Ercan MT; Kontaş O; Aydin M; Doğan H Ann Nucl Med; 1997 May; 11(2):143-6. PubMed ID: 9212895 [TBL] [Abstract][Full Text] [Related]
12. Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma. Blend MJ; Hyun H; Patel B; Sullivan K; Salk D J Nucl Med; 1996 Feb; 37(2):252-7. PubMed ID: 8667055 [TBL] [Abstract][Full Text] [Related]
13. [Immunoscintigraphy results in the comparison of ocular with cutaneous melanoma]. Löffler KU; Bräutigam P; Simon J; Althauser SR; Moser E; Witschel H Ophthalmologe; 1994 Aug; 91(4):529-32. PubMed ID: 7950129 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of ocular melanoma immunoscintigraphy. Janković Z; Pucar D; Jauković L; Ajdinović B J BUON; 2006; 11(3):347-50. PubMed ID: 17309161 [TBL] [Abstract][Full Text] [Related]
16. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2. van Dongen GA; Leverstein H; Roos JC; Quak JJ; van den Brekel MW; van Lingen A; Martens HJ; Castelijns JA; Visser GW; Meijer CJ Cancer Res; 1992 May; 52(9):2569-74. PubMed ID: 1568225 [TBL] [Abstract][Full Text] [Related]
17. Improved immunoscintigraphy by subcutaneous injection of 99mTc or 111In labelled F(ab')2 fragments of an anti-melanoma monoclonal antibody. Paganelli G; Riva P; Moscatelli G; Stacchiotti A; Agostini M; Landi G; Tison V; Pancea P; Siccardi AG Int J Rad Appl Instrum B; 1986; 13(4):423-8. PubMed ID: 3793497 [TBL] [Abstract][Full Text] [Related]
18. Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma. Cerny T; Owens SE; Mackenzie SA; Nuttall PM; Gosh AK; Smith DB; Thatcher N Eur J Nucl Med; 1987; 13(3):130-3. PubMed ID: 3622556 [TBL] [Abstract][Full Text] [Related]
19. Immunoscintigraphy in intraocular malignant melanoma. Scheidhauer K; Markl A; Leinsinger G; Moser E; Scheiffarth OF; Riedel KG; Schaal TS; Stefani FH; Schumacher U Nucl Med Commun; 1988 Sep; 9(9):669-78. PubMed ID: 3263596 [TBL] [Abstract][Full Text] [Related]